Clinical Scorecard: Diabetes Risk Assessment: A New Approach

At a Glance

Key Highlights

• Single blood draw for DNA methylation profiling can distinguish high- and low-risk individuals.
• Machine learning workflow enhances risk stratification using 1557 methylation sites.
• Cost-effective and time-saving alternative to traditional glucose tolerance testing.

Guideline-Based Recommendations

Diagnosis

• Utilize epigenetic markers for early identification of prediabetes.

Management

• Implement early interventions based on risk stratification to prevent T2D onset.

Monitoring & Follow-up

• Regular assessment of DNA methylation profiles to track risk changes.

Risks

• Potential complications of T2D can be predicted using epigenetic markers.

Patient & Prescribing Data

Individuals with prediabetes or at high risk for T2D.

Early intervention strategies tailored to specific risk clusters can improve metabolic health.

Clinical Best Practices

• Adopt epigenetic testing for broader population screening.
• Refine and simplify testing protocols for clinical use.

References

• Biomarker Research